pyrroles has been researched along with natriuretic peptide, brain in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 17 (47.22) | 29.6817 |
| 2010's | 19 (52.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernard, D; De Backer, G; De Bacquer, D; De Buyzere, M; De Sutter, J; Jordaens, L; Langlois, M; Matthys, K; Tavernier, R; Van de Veire, NR | 1 |
| Braunwald, E; Cannon, CP; Jarolim, P; McCabe, CH; Morrow, DA; Ray, KK; Sabatine, MS; Scirica, BM; Shui, A | 1 |
| Agustín Herrero, J; Cámara Hijón, C; Costo Campoamor, A; Crespo Rincón, L; Fernández Pereira, L; Pereira Navarro, G; Sánchez Muñoz-Torrero, JF; Torres Pérez, F | 1 |
| Fukunami, M; Kioka, H; Masuda, M; Mine, T; Morita, T; Node, K; Okuda, K; Tamaki, S; Tsukamoto, Y; Yamada, T | 1 |
| Bech, JN; Holm, C; Paulsen, L; Pedersen, EB; Starklint, J | 1 |
| Chen, HJ; Chen, JZ; Chen, TG; Wang, LH; Yao, L; Yu, M | 1 |
| Ferjan, M; Golicnik, A; Okrajsek, R; Radovancevic, B; Schlegel, TT; Starc, V; Vrtovec, B | 1 |
| Asakura, M; Asanuma, H; Kato, H; Kim, J; Kitakaze, M; Liao, Y; Minamino, T; Ogai, A; Takashima, S; Zhao, H | 1 |
| Kim, JH; Kim, JS; Kim, WS; Lee, SH; Lee, YT; On, YK; Shin, DH; Song, YB; Sung, J | 1 |
| Fujii, N; Igarashi, N; Inoue, H; Matsuki, A; Nozawa, T; Sobajima, M; Suzuki, T | 1 |
| Alber, HF; Bartel, T; Dichtl, W; Feuchtner, GM; Grander, W; Hintringer, F; Müller, S; Pachinger, O; Reinthaler, M; Süssenbacher, A; Ulmer, H | 1 |
| Assmann, G; Breithardt, G; Nofer, JR; Schubert, A; Schulte, H; Stypmann, J; Welp, H | 1 |
| Bech, JN; Holst, LM; Paulsen, L; Pedersen, EB; Starklint, J | 1 |
| Akioka, H; Anan, F; Hara, M; Iwao, T; Nakagawa, M; Saikawa, T; Takahashi, N; Teshima, Y; Yonemochi, H; Yufu, K | 1 |
| Cui, W; Du, J; Han, M; Liu, DM; Liu, F; Lu, JC; Yin, HN; Zhang, HL; Zhang, K | 1 |
| Kishi, T; Okamatsu, S; Sunagawa, K; Yamada, A | 1 |
| Banach, M; Bielecka-Dabrowa, A; Goch, JH; Maciejewski, M; Mikhailidis, DP; Rysz, J | 1 |
| Haseke, N; Stadler, T; Staehler, M; Stief, CG; Zilinberg, K | 1 |
| Aronow, WS; Banach, M; Bielecka-Dabrowa, A; Desai, R; Goch, JH; Maciejewski, M; Rysz, J | 1 |
| Andreadis, C; Antonakis, E; Christopoulou, M; Kontovinis, LF; Kortsaris, AH; Kouvatseas, G; Lafaras, C; Mouratidou, D; Papandreou, CN; Papazisis, KT | 1 |
| Fujii, M; Horie, M; Ibe, K; Kawahara, C; Nakae, I; Sakai, H; Tsutamoto, T; Yamaji, M; Yamamoto, T | 1 |
| Korkor, MT; Liu, B; Liu, JY; Song, XJ; Wei, Q; Yang, CY; Yang, P | 1 |
| Abulhul, E; Baugh, J; Hennessy, M; Ledwidge, M; Martos, R; McDonald, K; O'Loughlin, C; Phelan, D; Spiers, JP; Watson, C | 1 |
| Jing, LM; Li, H; Liu, HL; Luo, JP; Shen, ZQ; Yang, SL; Yang, Y | 1 |
| Chrysohoou, C; Dilaveris, P; Kioufis, S; Maniatis, K; Michalea, S; Miliou, A; Oikonomou, E; Papavassiliou, AG; Siasos, G; Stefanadis, C; Tousoulis, D; Zaromitidou, M | 1 |
| Bu, L; Cheng, Z; Dong, D; Huang, T; Shen, B; Tu, Y; Wan, L; Zhao, D | 1 |
| Bech, JN; Hansen, AB; Jensen, JM; Larsen, T; Mose, FH; Pedersen, EB | 1 |
| Ahmad, SF; Al-Suwayeh, HA; Ansari, MA; Bakheet, SA; Korashy, HM; Maayah, ZH | 1 |
| Chen, W; Gao, DC; Ye, PX; Ye, PZ; Zhu, JH | 1 |
| Luo, YQ; Xu, Y; Yang, Y | 1 |
| Choi, D; Hong, N; Kang, SM; Lee, SH; Oh, J; Park, S; Youn, JC | 1 |
| Akiyama, E; Kimura, K; Kosuge, M | 1 |
| Chitose, T; Hokamaki, J; Ogawa, H; Sakamoto, K; Shimomura, H; Shiraishi, S; Sugiyama, S; Tsunoda, R; Yamashita, T; Yamashita, Y | 1 |
| Chen, J; Hu, YJ; Peng, DF; Tang, SY | 1 |
| Arai, K; Homma, T; Tsuruoka, H | 1 |
| Engle, SK; Watson, DE | 1 |
1 review(s) available for pyrroles and natriuretic peptide, brain
| Article | Year |
|---|---|
Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study.
Topics: Acute Disease; Atorvastatin; Cardiac Output, Low; Coronary Disease; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Natriuretic Peptide, Brain; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Risk Assessment; Syndrome | 2006 |
19 trial(s) available for pyrroles and natriuretic peptide, brain
| Article | Year |
|---|---|
Coronary risk factors and inflammation in patients with coronary artery disease and internal cardioverter defibrillator implants.
Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Belgium; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Defibrillators, Implantable; Double-Blind Method; Female; Follow-Up Studies; Glycated Hemoglobin; Greece; Heptanoic Acids; Humans; Inflammation; Inflammation Mediators; Lipids; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prevalence; Pyrroles; Research Design; Risk Factors; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation | 2006 |
Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study.
Topics: Aged; Atorvastatin; Atrial Natriuretic Factor; Disease-Free Survival; Echocardiography; Female; Follow-Up Studies; Heart Failure; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Pyrroles; Stroke Volume; Ventricular Dysfunction, Left | 2007 |
Effects of statins on renal sodium and water handling: acute and short-term effects of atorvastatin on renal haemodynamics, tubular function, vasoactive hormones, blood pressure and pulse rate in healthy, normocholesterolemic humans.
Topics: Adult; Angiotensin II; Arginine Vasopressin; Atorvastatin; Atrial Natriuretic Factor; Blood Pressure; Cross-Over Studies; Diuresis; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Kidney Tubules; Male; Natriuresis; Natriuretic Peptide, Brain; Pyrroles; Renal Plasma Flow | 2008 |
Atorvastatin therapy may reduce the incidence of sudden cardiac death in patients with advanced chronic heart failure.
Topics: Atorvastatin; Death, Sudden, Cardiac; Disease Progression; Female; Health Status Indicators; Heart Failure; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Pyrroles; Risk Factors; Stroke Volume | 2008 |
The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off-pump coronary artery bypass grafting surgery.
Topics: Aged; Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Coronary Artery Bypass, Off-Pump; Elective Surgical Procedures; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Natriuretic Peptide, Brain; Peptide Fragments; Postoperative Complications; Premedication; Prospective Studies; Pyrroles | 2008 |
Prognosis and risk factors in patients with asymptomatic aortic stenosis and their modulation by atorvastatin (20 mg).
Topics: Aged; Aortic Valve; Aortic Valve Stenosis; Atorvastatin; C-Reactive Protein; Calcinosis; Cholesterol; Disease Progression; Female; Heart Valve Prosthesis; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Multivariate Analysis; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Prospective Studies; Pyrroles; Risk Factors; Tomography, X-Ray Computed | 2008 |
Atorvastatin therapy is associated with reduced levels of N-terminal prohormone brain natriuretic peptide and improved cardiac function in patients with heart failure.
Topics: Atorvastatin; Echocardiography; Follow-Up Studies; Heart Failure; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoassay; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Protein Precursors; Pyrroles; Retrospective Studies; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2008 |
Glomerular filtration rate and blood pressure are unchanged by increased sodium intake in atorvastatin-treated healthy men.
Topics: Adult; Aldosterone; Angiotensin II; Aquaporin 2; Atorvastatin; Atrial Natriuretic Factor; Blood Pressure; Female; Glomerular Filtration Rate; Heptanoic Acids; Humans; Kidney Function Tests; Lithium; Male; Natriuretic Peptide, Brain; Pyrroles; Renin; Sodium; Vasopressins | 2009 |
Early atorvastatin therapy improves cardiac function in patients with acute myocardial infarction.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Atrial Natriuretic Factor; Cholesterol; Echocardiography; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardial Infarction; Natriuretic Peptide, Brain; Prospective Studies; Pyrroles; Stroke Volume; Triglycerides; Ventricular Remodeling | 2009 |
The influence of atorvastatin on parameters of inflammation and function of the left ventricle in patients with dilated cardiomyopathy.
Topics: Aged; Atorvastatin; Cardiomyopathy, Dilated; Exercise Test; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Interleukin-10; Interleukin-6; Lipids; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Pyrroles; Time Factors; Tumor Necrosis Factor-alpha; Ventricular Function, Left | 2009 |
Influence of co-existing atrial fibrillation on the efficacy of atorvastatin treatment in patients with dilated cardiomyopathy: a pilot study.
Topics: Adult; Aged; Atorvastatin; Atrial Fibrillation; Body Mass Index; Cardiomyopathy, Dilated; Echocardiography; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-10; Interleukin-6; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Pilot Projects; Prospective Studies; Pyrroles; Tumor Necrosis Factor-alpha | 2010 |
Effect of atorvastatin vs. rosuvastatin on cardiac sympathetic nerve activity in non-diabetic patients with dilated cardiomyopathy.
Topics: Aged; Atorvastatin; Cardiomyopathy, Dilated; Female; Fluorobenzenes; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Pyrimidines; Pyrroles; Radionuclide Imaging; Rosuvastatin Calcium; Stroke Volume; Sulfonamides; Sympathetic Nervous System; Time Factors | 2011 |
Long-term statin therapy in patients with systolic heart failure and normal cholesterol: effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Atorvastatin; Biomarkers; Chi-Square Distribution; Cholesterol; Collagen; Collagen Type I; Down-Regulation; Female; Heart Failure, Systolic; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Ireland; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Peptides; Procollagen; Prospective Studies; Pyrroles; Recovery of Function; Stroke Volume; Time Factors; Treatment Outcome; Up-Regulation; Ventricular Function, Left | 2012 |
Administration of a loading dose of atorvastatin before percutaneous coronary intervention prevents inflammation and reduces myocardial injury in STEMI patients: a randomized clinical study.
Topics: Aged; Atorvastatin; C-Reactive Protein; Combined Modality Therapy; Echocardiography; Female; Heptanoic Acids; Humans; Inflammation; Male; Matrix Metalloproteinase 9; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Percutaneous Coronary Intervention; Prospective Studies; Pyrroles; Ventricular Function, Left | 2013 |
Dose-dependent effects of short term atorvastatin treatment on arterial wall properties and on indices of left ventricular remodeling in ischemic heart failure.
Topics: Aged; Arteries; Atorvastatin; Cholesterol, LDL; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intercellular Adhesion Molecule-1; Male; Matrix Metalloproteinase 9; Middle Aged; Myocardial Ischemia; Natriuretic Peptide, Brain; Pyrroles; Regression Analysis; Ventricular Remodeling | 2013 |
Effect of atorvastatin on renal NO availability and tubular function in patients with stage II-III chronic kidney disease and type 2 diabetes.
Topics: Aged; Arginine Vasopressin; Atorvastatin; Atrial Natriuretic Factor; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Tubules; Male; Middle Aged; Natriuretic Peptide, Brain; Nitric Oxide; omega-N-Methylarginine; Pulse Wave Analysis; Pyrroles; Renal Insufficiency, Chronic; Treatment Outcome; Vascular Stiffness; Vasopressins | 2014 |
[Effect of atorvastatin on exercise tolerance in patients with diastolic dysfunction and exercise-induced hypertension].
Topics: Aged; Atorvastatin; C-Reactive Protein; Double-Blind Method; Endothelins; Exercise Tolerance; Female; Heart Failure; Heptanoic Acids; Humans; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Pyrroles | 2014 |
Effect of high-dose statin loading on biomarkers related to inflammation and renal injury in patients hospitalized with acute heart failure. Randomized, controlled, open-label, prospective pilot study.
Topics: Acute Kidney Injury; Administration, Oral; Aged; Aged, 80 and over; Atorvastatin; Biomarkers; Female; Heart Failure; Heptanoic Acids; Hospital Mortality; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Pilot Projects; Prospective Studies; Pyrroles | 2014 |
Effect of a hydrophilic and a hydrophobic statin on cardiac salvage after ST-elevated acute myocardial infarction - a pilot study.
Topics: Aged; Atorvastatin; Cholesterol, LDL; Echocardiography; Fatty Acids; Female; Fluorobenzenes; Heart; Heptanoic Acids; Humans; Hydrophobic and Hydrophilic Interactions; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iodobenzenes; Male; Middle Aged; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; Pilot Projects; Prospective Studies; Pyrimidines; Pyrroles; Radionuclide Imaging; Rosuvastatin Calcium; Sulfonamides; Thallium; Tomography, Emission-Computed, Single-Photon; Ubiquinone | 2014 |
16 other study(ies) available for pyrroles and natriuretic peptide, brain
| Article | Year |
|---|---|
[Effects of atorvastatin in N-terminal pro-brain natriuretic peptide plasma levels in hypercholesterolemic patients with or without hypertension].
Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Pyrroles | 2006 |
Atorvastatin prevents connexin43 remodeling in hypertrophied left ventricular myocardium of spontaneously hypertensive rats.
Topics: Animals; Anticholesteremic Agents; Atorvastatin; Blood Pressure; Blotting, Western; Connexin 43; Heart; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Immunohistochemistry; Lipid Metabolism; Lipids; Male; Microscopy, Electron, Transmission; Myocardium; Natriuretic Peptide, Brain; Pyrroles; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2007 |
Atorvastatin slows the progression of cardiac remodeling in mice with pressure overload and inhibits epidermal growth factor receptor activation.
Topics: Animals; Atorvastatin; Cardiomegaly; Disease Progression; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Heart Failure; Heparin-binding EGF-like Growth Factor; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intercellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Natriuretic Peptide, Brain; Phosphorylation; Pyrroles; Ventricular Function, Left | 2008 |
Atorvastatin-induced changes in plasma coenzyme q10 and brain natriuretic peptide in patients with coronary artery disease.
Topics: Aged; Atorvastatin; Chromatography, High Pressure Liquid; Coronary Artery Disease; Dose-Response Relationship, Drug; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoassay; Natriuretic Peptide, Brain; Oxidative Stress; Pyrroles; Treatment Outcome; Ubiquinone | 2008 |
Additive beneficial effects of amlodipine and atorvastatin in reversing advanced cardiac hypertrophy in elderly spontaneously hypertensive rats.
Topics: Aging; Amlodipine; Animals; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Cardiomegaly; Drug Synergism; Drug Therapy, Combination; Fibrosis; Heart Failure, Diastolic; Hemodynamics; Heptanoic Acids; Myocytes, Cardiac; NADPH Oxidases; Natriuretic Peptide, Brain; Oxidative Stress; Pyrroles; Random Allocation; Rats; Rats, Inbred SHR; Reactive Oxygen Species; Superoxide Dismutase; Ventricular Dysfunction, Left | 2009 |
Atorvastatin might improve ventricular electrostability and decelerate the deterioration of renal function in patients with heart failure and diabetes mellitus.
Topics: Aged; Atorvastatin; Diabetes Mellitus; Female; Glomerular Filtration Rate; Heart Failure; Heart Ventricles; Heptanoic Acids; Hospitalization; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Pyrroles; Retrospective Studies; Ventricular Premature Complexes | 2009 |
Plasma N-terminal pro-brain natriuretic peptide as prognostic marker in fatal cardial decompensation with sunitinib malate therapy.
Topics: Aged; Carcinoma, Renal Cell; Echocardiography; Heart Failure; Humans; Indoles; Kidney Neoplasms; Lung Neoplasms; Male; Natriuretic Peptide, Brain; Neoplasm Metastasis; Prognosis; Pyrroles; Retrospective Studies; Sunitinib; Thrombosis | 2010 |
Brain natriuretic peptide precursor (NT-pro-BNP) levels predict for clinical benefit to sunitinib treatment in patients with metastatic renal cell carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Biomarkers; Bone Neoplasms; Carcinoma, Renal Cell; Female; Humans; Indoles; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Pyrroles; Sunitinib | 2010 |
Atorvastatin inhibits myocardial cell apoptosis in a rat model with post-myocardial infarction heart failure by downregulating ER stress response.
Topics: Animals; Apoptosis; Atorvastatin; Caspase 12; Cells, Cultured; Disease Models, Animal; Endoplasmic Reticulum Stress; Female; Heart Failure; Heat-Shock Proteins; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Situ Nick-End Labeling; Myocardial Infarction; Natriuretic Peptide, Brain; Pyrroles; Rats; Rats, Wistar; Transcription Factor CHOP | 2011 |
MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention.
Topics: Angiotensin II; Animals; Anticholesteremic Agents; Atorvastatin; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Down-Regulation; Heptanoic Acids; Male; Mice; MicroRNAs; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; Oligonucleotides, Antisense; Phosphoric Monoester Hydrolases; PTEN Phosphohydrolase; Pyrroles; Rats | 2013 |
Mitogen-activated protein kinases pathways mediate the sunitinib-induced hypertrophy in rat cardiomyocyte H9c2 cells.
Topics: Animals; Antineoplastic Agents; Biomarkers; Blotting, Western; Cardiac Myosins; Cell Line; Cell Survival; Enzyme Inhibitors; Flow Cytometry; Gene Expression Regulation; Indoles; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; Pyrroles; Rats; Real-Time Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Sunitinib | 2015 |
Effect of atorvastatin on serum oxidative stress and N-terminal brain natriuretic peptide expression in rats.
Topics: Animals; Atorvastatin; Heptanoic Acids; Male; Myocardial Reperfusion Injury; Natriuretic Peptide, Brain; Oxidative Stress; Peptide Fragments; Pyrroles; Rats; Rats, Sprague-Dawley | 2014 |
Is high-dose statin loading effective for acute decompensated heart failure? Insight of inflammation and acute kidney injury.
Topics: Acute Kidney Injury; Atorvastatin; Female; Heart Failure; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Natriuretic Peptide, Brain; Peptide Fragments; Pyrroles | 2014 |
Protective effects of valsartan and benazepril combined with atorvastatin on cardiorenal syndrome in rats.
Topics: Angiotensin II; Animals; Atorvastatin; Benzazepines; C-Reactive Protein; Cardio-Renal Syndrome; Case-Control Studies; Drug Synergism; Heptanoic Acids; Lipids; Male; Natriuretic Peptide, Brain; Proteinuria; Pyrroles; Random Allocation; Rats; Rats, Sprague-Dawley; Tetrazoles; Valine; Valsartan | 2015 |
CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cytoprotection; Heart; Hypertension; Kidney; Male; Mineralocorticoid Receptor Antagonists; Natriuretic Peptide, Brain; Organ Size; Potassium; Pyrroles; Rats; Rats, Inbred Dahl; Receptors, Mineralocorticoid; Safety; Sulfones | 2015 |
Natriuretic Peptides as Cardiovascular Safety Biomarkers in Rats: Comparison With Blood Pressure, Heart Rate, and Heart Weight.
Topics: Animals; Atrial Natriuretic Factor; Biomarkers; Blood Pressure; Cardiomegaly; Heart Rate; Indoles; Male; Minoxidil; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nifedipine; Organ Size; Peptide Fragments; Prostaglandins F, Synthetic; Pyrroles; Rats; Rats, Sprague-Dawley; Sunitinib; Thyroxine | 2016 |